Insider · CIK 0001035422
CTT PHARMACEUTICAL HOLDINGS, INC.
ceoofficer
Files at CTTH (CTT PHARMACEUTICAL HOLDINGS, INC.). First filing Nov 26, 2024, latest Mar 31, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
5 / 0
$4,200 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 25Weak | buy | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | $776 | 15,510 | +0% | - | |
| 25Weak | buy | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | $324 | 5,400 | +0% | - | |
| 25Weak | buy | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | $1,076 | 11,950 | +0% | - | |
| 25Weak | buy | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | $624 | 5,200 | +0% | - | |
| 20Weak | buy | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | $1,401 | 23,346 | +0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | POpen-market purchase CTTH | +15,510 | $0.05 | $776 | 6,590,416 | Mar 31, 2025 |
| Mar 11, 2025 | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | POpen-market purchase CTTH | +5,400 | $0.06 | $324 | 6,574,906 | Mar 14, 2025 |
| Mar 7, 2025 | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | POpen-market purchase CTTH | +11,950 | $0.09 | $1,076 | 6,569,506 | Mar 10, 2025 |
| Feb 5, 2025 | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | POpen-market purchase CTTH | +5,200 | $0.12 | $624 | 6,557,556 | Feb 6, 2025 |
| Nov 25, 2024 | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | POpen-market purchase CTTH | +23,346 | $0.06 | $1,401 | 5,818,846 | Nov 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.